McKinsey August 21, 2025

With the support of McKinsey, the organization launched an expansion of clinical trial capacity at research sites across the United States, enabling more than 20 new trials and reaching over 4,600 participants to date.

THE OPPORTUNITY

Expanding participation in clinical research, community by community

Clinical research is the cornerstone of medical innovation, yet access to clinical trials remains disproportionately limited to a small fraction of the population.

Enter Clinical Trials Access Collaborative (CTAC), an organization dedicated to making medical research more accessible, striving to ensure those who wish to participate in clinical trials can do so. CTAC, which is currently applying for a 501(c)(3) status, grew from a preceding grant and learning phase, Equitable Breakthroughs in Medicine Development (EQBMED).

The...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Clinical Trials, Trends
Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs
Trial acceleration: AI supports progress, relationships drive success
Walmart Health Research Institute to Host Clinical Trials at 4 New Sites
Walmart To Launch Clinical Research Sites In Shuttered Health Clinics
2026: The time for AI to really deliver

Share Article